Authors: Luukinen, H Kakonen, SM Pettersson, K Koski, K Laippala, P Lovgren, T Kivela, SL Vaananen, HK

Citation: H. Luukinen et al., Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin, J BONE MIN, 15(12), 2000, pp. 2473-2478

Authors: Pullig, O Weseloh, G Ronneberger, DL Kakonen, SM Swoboda, B

Citation: O. Pullig et al., Chondrocyte differentiation in human osteoarthritis: Expression of osteocalcin in normal and osteoarthritic cartilage and bone, CALCIF TIS, 67(3), 2000, pp. 230-240

Authors: Kakonen, SM Hellman, J Karp, M Laaksonen, P Obrant, KJ Vaananen, HK Lovgren, T Pettersson, K

Citation: Sm. Kakonen et al., Development and evaluation of three immunofluorometric assays that measuredifferent forms of osteocalcin in serum, CLIN CHEM, 46(3), 2000, pp. 332-337

Authors: Obrant, KJ Kakonen, SM Astermark, J Lilja, H Lovgren, T Akesson, K Pettersson, K

Citation: Kj. Obrant et al., The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects, J BONE MIN, 14(4), 1999, pp. 555-560

Authors: Matikainen, T Kakonen, SM Pettersson, K Karp, M Lovgren, T Vaananen, HK Hellman, J

Citation: T. Matikainen et al., Demonstration of the predominant urine osteocalcin fragments detectable bytwo-site immunoassays, J BONE MIN, 14(3), 1999, pp. 431-438

Authors: Halleen, JM Karp, M Viloma, S Laaksonen, P Hellman, J Kakonen, SM Stepan, JJ Holmes, S Vaananen, HK Pettersson, K

Citation: Jm. Halleen et al., Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatasebased on characterization of six monoclonal antibodies, J BONE MIN, 14(3), 1999, pp. 464-469